Loureirin B promotes insulin secretion mainly through increasing Pdx-1, MafA, and intracellular ATP levels, inhibiting the KATP current, and the influx of Ca2+ to the intracellular.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.